December 9, 2024
Throughout your nasal spray development journey, you are likely to face pressure to accelerate timelines to clinical phases, stemming from the need to:
READ MORE READ MORE
September 30, 2024
Renaissance Lakewood, LLC (“Renaissance”), a leading global contract development and manufacturing organization (“CDMO”) is proud to be manufacturing neffy®, which is now commercially available in the US.
READ MORE READ MORE
September 3, 2024
Renaissance Lakewood, LLC (“Renaissance”), a leading pharmaceutical contract development and manufacturing organization (CDMO), today announced the official opening of their new, 67,000 sq ft, expansive warehouse at their recently opened headquarters at 1215 Paco Way in Lakewood, NJ.
READ MORE READ MORE
May 14, 2024
LAKEWOOD, NJ (05/14/24) – Renaissance Lakewood, LLC, a leading pharmaceutical contract development and manufacturing organization (CDMO), today announced the official opening of their new headquarters at 1215 Paco Way in Lakewood, NJ.
READ MORE READ MORE
September 13, 2023
LAKEWOOD, NJ (9/13/23) – Renaissance Lakewood, LLC, a leading pharmaceutical contract development and manufacturing organization (CDMO), has announced a significant expansion of their Quality Control Spray/Particulate Laboratory as well as both of their Analytical and Formulation Research and Development laboratories in Ocean County, NJ.
READ MORE READ MORE
October 19, 2022
Overview: The following case study is a collaboration with Renaissance Lakewood and Raven consulting on continuous...
READ MORE READ MORE
June 11, 2021
Nasal spray devices are used to deliver both locally and systemically acting pharmaceutical products,1 and are readily available in the marketplace in unit dose and metered multi-dose formats.
READ MORE READ MORE"*" indicates required fields